U.S. Healthcare Services Stock News

Vanda Pharmaceuticals Inc.'s (NASDAQ:VNDA) value has fallen 11% in the last week, but insiders who sold US$2.8m worth...

It's common for many investors, especially those who are inexperienced, to buy shares in companies with a good story...

Cars.com Inc. ( NYSE:CARS ), is not the largest company out there, but it received a lot of attention from a...

Even when a business is losing money, it's possible for shareholders to make money if they buy a good business at the...

Spotify Technology (SPOT) has drawn fresh investor attention after introducing transparency tools that flag whether tracks are human-made or use generative AI, while also expanding efforts to remove low-quality AI-generated content. See our latest analysis for Spotify Technology. Recent feature launches, including Spotify Technology's conversational interface and parent-managed accounts, arrive as momentum has cooled. The share price is down 15.6% year to date and the 1-year total shareholder...

La-Z-Boy (LZB) is rolling out an upgraded 3D Cloud platform that gives shoppers photorealistic views of every furniture configuration while reducing manual rendering work, a move that directly affects how the stock’s story relates to digital execution. See our latest analysis for La-Z-Boy. The 3D Cloud rollout lands at a time when La-Z-Boy’s 1-day share price return of 3.5% to $39.93 feeds into a 90-day share price return of 17.1%. The 3-year total shareholder return of 36.4% points to...

Quantum computing stocks sit at the crossroads of advanced research and real world problem solving, which can appeal to investors looking for growth stories not solely tied to traditional interest rate or inflation trends. While global data show moderating inflation in several regions and mixed growth signals across developed and emerging markets, capital continues to search for technologies that may reshape areas like logistics, materials science, and security. This Quantum Computing Stocks...

AbbVie stock has returned 150.7% over the past five years, yet its current checks present a split picture, with an intrinsic value estimate from a Discounted Cash Flow (DCF) model pointing to significant upside while market based multiples lean the other way. A 150.7% return over five years signals that AbbVie has already rewarded long term holders, which can make fresh valuation calls more sensitive to what happens next. On the upside, expectations around continued contributions from key...

Earlier this month, Vera Therapeutics received FDA accelerated approval for TRUTAKNA (atacicept-vymj) to reduce proteinuria in adults with primary IgA nephropathy at risk for disease progression, based on interim Phase 3 data from the ongoing ORIGIN 3 trial. The approval makes TRUTAKNA the first therapy to target both BAFF and APRIL in IgA nephropathy, offering a differentiated mechanism via a once-weekly, self-administered autoinjector and underscoring Vera’s growing regulatory and...

US trade policy is back in the spotlight, with fresh signals on Section 301 tariffs for Brazil, a new trade surplus with Switzerland, and renewed scrutiny on China, especially around rare earths. That mix can reshape export flows, input costs, and pricing power for US industrials. For investors, it can mean fresh risks for some companies and potential tailwinds for others that are aligned with shifting trade routes. This article looks at 3 stocks from a US Export-Oriented Industrials screener...

On 14 July 2026, Arteris, Inc. reported that Arm is expanding its use of Arteris’ Cycuity Radix hardware security assurance technology across additional next‑generation CPU development programs to strengthen early-stage security verification and vulnerability mitigation. This deeper integration of Cycuity Radix into Arm’s design flow highlights Arteris’ growing role in addressing hardware security risks earlier in the silicon lifecycle. Next, we’ll examine how Arm’s broader integration of...

Nike, NYSE:NKE, is reportedly at risk of being removed from the Dow Jones Industrial Average, raising questions about its role in a key U.S. equity benchmark. The company is shifting away from a digital first playbook, putting more emphasis back on traditional retail partners and wholesale distribution. These changes follow reported declines in Direct and Nike Digital sales and arrive alongside broader adjustments to the business model. Nike enters this period of change with its share price...

Shopify (SHOP) is back in focus after DoorDash announced a direct integration that lets US brick and mortar Shopify retailers plug into its delivery marketplace through a native sales channel and simplified onboarding. See our latest analysis for Shopify. That integration comes as Shopify’s share price sits at US$123.55, with a 7 day share price return of 3.63% and a 30 day share price return of 9.83% after a tougher year to date. The 3 year total shareholder return of 81.08% contrasts with a...

Elastic (NYSE:ESTC) is back in focus after Elastic Security earned the only 100% malware protection score in AV-Comparatives’ 2026 Business Security Test and received the firm’s Approved Business Product Award. See our latest analysis for Elastic. The AV-Comparatives recognition arrives during a mixed period for Elastic’s stock, with the share price up 30.59% over the past 90 days but down 14.22% year to date and the 1 year total shareholder return declining 26.81%. If this security-focused...

Tensions in the Strait of Hormuz are back in focus, with renewed disruption to oil shipping routes and Brent crude trading at $85.38 per barrel in Asian hours. For energy sector investors, this kind of shock can quickly reshape expectations for cash flows, balance sheet strength, and price risk. This article looks at three large oil and gas producers from our Energy Sector Stocks screener that appear more directly exposed to the latest US Iran flare up and the resulting pressure on global...

Baidu (NasdaqGS:BIDU) has drawn investor attention after recent share price moves, with the stock up 1.6% over the past day but down over the past week, month, and past 3 months. See our latest analysis for Baidu. Zooming out, Baidu’s recent share price return has been weak, with the stock down 25.83% year to date despite a 29.15% total shareholder return over the past year. This contrast suggests sentiment has cooled after a stronger prior period. If Baidu’s moves have you reassessing your...

Scotts Miracle-Gro (SMG) stock has attracted fresh attention after recent share price moves, with investors weighing its current valuation against fundamentals such as revenue of $3,470.8m and net income of $206.1m. See our latest analysis for Scotts Miracle-Gro. At a latest share price of $67.99, Scotts Miracle-Gro has seen short term momentum pick up, with a 7.63% 1 month share price return and a 14.40% year to date share price return. The 5 year total shareholder return is down 55.04%,...

Leidos Holdings (LDOS) is back in focus after new AI partnerships aimed at military logistics and federal data modernization, prompting investors to reassess how these deals fit with the stock’s long term growth priorities. See our latest analysis for Leidos Holdings. Leidos Holdings’ recent AI deals come as the stock trades at $108.21, with the 1-day share price return of 1.55% and 7-day share price return of 0.96% contrasting with a much weaker 90-day share price return. The 3-year total...

Hesai Group (HSAI) is in focus after shareholders approved an 8-for-1 stock split at the June annual meeting, effective July 10, 2026, along with updates on its lidar role with Mercedes-Benz. See our latest analysis for Hesai Group. The stock split and Mercedes-Benz lidar partnership arrive after a mixed run for Hesai Group, with the share price down 15.6% over 30 days and 34.2% year to date. However, a 3 year total shareholder return of 34.1% points to earlier momentum that has since...

Chemours stock has delivered a strong 51.1% gain year to date, yet its valuation checks still suggest the shares lean cheap rather than stretched after that run. Year to date, Chemours is up 51.1%, which puts recent weakness into context for investors weighing whether the move has already priced in the good news. Expectations around how Chemours can convert demand trends in its end markets into durable cash flows, while managing environmental and regulatory risks linked to its operations,...

Piper Sandler Companies (PIPR) is in focus after hosting its Virtual Ophthalmology Day in Miami on July 9, 2026. The event highlighted the firm’s healthcare focus alongside its role in capital markets. See our latest analysis for Piper Sandler Companies. Recent moves in Piper Sandler Companies’ stock have been mixed, with a 1 day share price return of 3.75% and 7 day share price return of 9.68%, but a 90 day share price return that is down 12.46%. The 5 year total shareholder return of...

CRISPR Therapeutics stock has given up around 60% over the past five years, yet recent checks suggest it now sits closer to a fair, middle-of-the-road valuation rather than being clearly cheap or clearly expensive. Over five years the share price has declined about 60%, which sets expectations low and puts more focus on whether the current valuation fairly reflects the company’s prospects. Strong cash reserves of about US$2.4b and a growing gene editing pipeline can support long development...

Waste Connections (WCN) is back on investors’ radar after recent share price moves, with the stock closing at US$170.12 as multi year returns and current valuation metrics draw closer scrutiny. See our latest analysis for Waste Connections. Recent trading suggests momentum in Waste Connections is rebuilding, with a 30 day share price return of 9.77% and a 90 day share price return of 6.33%, set against a declining year to date share price return and a mixed multi year total shareholder return...

Hycroft Mining Holding (HYMC) is back in focus after the company appointed Michael Deal as Senior Vice President and Chief Operating Officer. The move is centered on strengthening its gold and silver mining operations. See our latest analysis for Hycroft Mining Holding. Despite the leadership update, Hycroft Mining Holding’s recent 30 day share price return is down 25% and its 90 day share price return is down 49%, while the 1 year total shareholder return remains very large. This suggests...